Your Recent Quotes: 0 | 0

Biogen IDEC Incorporated

Related Information and Financials
Price Glossary Definition
46.50 -2.89
-5.85%
10/07/08 4:00
Open
49.57
Prev Close
49.39
Volume
5,954,965
52 Wk. Range
45.37-84.75
Year-to-Date Performance Glossary Definition
DOWN  -18.31%
Latest Dividend
Dividend
N/A
Yield
N/A
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
21.02
 
21.50
 
16.00
BIIB
Sect. Av.
S&P 500
Market Cap
14,335,645,100
Outstanding Shares
297,751,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy BIIB Rating Report
Target Price (1Yr)
High
73.00
Revenue
4.10B

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
19.30
0.43
0.13
Net Income
198.60
24.44
1.91
EPS
221.00
27.86
2.03

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-21.01
-31.24
23.31
Earnings Per Share($)

12/2005
 
 
 
0.48
12/2006
 
 
 
0.63
12/2007
 
 
 
2.02

Earnings
EBITDA
331,858,000
Revenue
2.25B
Outside Analyst Rating History

10/8/08
4
Buy
10/8/08
8
Hold
10/8/08
3
Sell

Jim Cramer Portfolio
Find out now if BIIB is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
Latest Headlines
In this September 29 'Mad Money' clip Jim Cramer and Henri Termeer give insight on GENZ' business.

08:48PM 10/05/08

Watch Video
Video
Amgen rises on an upheld court ruling regarding two anemia drugs. Mentor shares fall on UBS rating.

3:08PM 10/03/08

The trading panel says health care stocks offer a way to get back into the market.

7:22PM 10/02/08

Biotech and pharma stocks got walloped with the rest of the market as the House rejected a financial-sector bailout measure.

3:58PM 09/29/08

Nuvelo rises on merger news.

5:26PM 09/25/08

Vertex shares fell Monday after the pharmaceutical company expanded its stock sale.

4:22PM 09/22/08

Large shareholders are clamoring for change at these companies; their bets may be worth piggybacking.

7:04AM 09/17/08

Bristol and ImClone shares fall as more drama unfolds surrounding their potential merger. King Pharmaceuticals' shares are down after it increased its bid for Alpharma.

4:26PM 09/11/08

Gains by Cephalon and Genzyme help boost the Amex biotech index. Amylin shares fall 1.7% after talks about pancreatitis and diabetes drug Byetta.

5:39PM 09/05/08

The FDA will update the companies' MS drug prescription.

6:05PM 08/26/08

Understanding the Market

Our Experts' Take at RealMoney
The shorts are likely planning an assault on this stock. How it holds up will tell us a lot.

7:18PM 10/07/08

Chattem gets punished for no reason along with Illinois Tool Works.

6:13PM 10/07/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading BIIB in his Action Alerts Plus Portfolio?